Sabre Corpo (SABR)
Cash ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 724,479 | 648,207 | 794,888 | 978,352 | 1,499,660 |
Short-term investments | US$ in thousands | 555 | 51,970 | 54,303 | 0 | 24,265 |
Total current liabilities | US$ in thousands | 1,141,780 | 914,713 | 815,571 | 716,505 | 621,943 |
Cash ratio | 0.64 | 0.77 | 1.04 | 1.37 | 2.45 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($724,479K
+ $555K)
÷ $1,141,780K
= 0.64
The cash ratio of Sabre Corpo has shown a declining trend over the past five years, indicating a decreasing ability to cover its short-term liabilities with its cash and cash equivalents. As of December 31, 2020, the cash ratio was 2.45, suggesting that the company had $2.45 in cash and cash equivalents for every dollar of its current liabilities. However, by December 31, 2024, the cash ratio had decreased to 0.64, implying that the company had only $0.64 in cash and cash equivalents for every dollar of its current liabilities.
This declining trend in the cash ratio may raise concerns about Sabre Corpo's liquidity position and its ability to meet its short-term obligations using its available cash resources. It is important for the company to closely monitor its cash position and possibly explore strategies to improve its liquidity in order to mitigate potential liquidity risks in the future.
Peer comparison
Dec 31, 2024